Last Updated : June 12, 2009
Details
FilesGeneric Name:
Clostridium botulinum neurotoxin type A, free from complexing proteins
Project Status:
Complete
Therapeutic Area:
Spasticity, Post-stroke
Manufacturer:
Merz Pharmaceuticals GmbH
Brand Name:
Xeomin
Project Line:
Reimbursement Review
Project Number:
SR0193-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Spasticity, Post-stroke
Recommendation Type:
Do not list
Final Recommendation:
Files
Last Updated : June 12, 2009